Evidence map›Paper›PMID 39713266›Full record

ArticleSAGE open medicine2024

The impact of mindfulness meditation on pro-inflammatory biomarkers in patients with end-stage renal disease: A randomized trial.

Hossam Alhawatmeh, Ishraq Najadat, Issa Hweidi, Sawsan Abuhammad

Registry-linked trialAbstract read
In one paragraph

Article in SAGE open medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06064708 (The Impact of Mindfulness-Based Intervention on Psychophysical Health in Patients Undergoing Hemodialysis), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06064708 nacompletednot on this map

The Impact of Mindfulness-Based Intervention on Psychophysical Health in Patients Undergoing Hemodialysis: An Experimental Study

TypeinterventionalSponsorJordan University of Science and TechnologyRan2023 to 2023Enrolled64ConditionsEnd Stage Renal DiseaseArmsMindfulness-based intervention
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hossam AlhawatmehThe Department of Adult Health Nursing, College of Nursing, Jordan University of Science and Technology, Irbid, Jordan.
Ishraq NajadatThe Department of Adult Health Nursing, College of Nursing, Jordan University of Science and Technology, Irbid, Jordan.
Issa HweidiThe Department of Adult Health Nursing, College of Nursing, Jordan University of Science and Technology, Irbid, Jordan.
Sawsan AbuhammadDepartment of Nursing, College of Health Sciences, University of Sharjah, Sharjah, UAE.ORCID https://orcid.org/0000-0001-5817-8950

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aim: Mindfulness meditation has been inadequately used in patients with end-stage renal disease although it has been effective in reducing pro-inflammatory biomarkers in patients with chronic illnesses. Thus, this study examined mindfulness meditation effect on pro-inflammatory biomarkers and C-reactive protein in patients with end-stage renal disease. Materials and methods: Repeated measures, randomized, control experimental design was used. A convenience sampling technique was used to select the sample from a hospital located in northern Jordan. The participants were randomly distributed into experimental ( Results: Compared to the control condition, mindfulness meditation led to statistically significant reductions in C-reactive protein and tumor necrosis factor over time but a nonsignificant effect on interleukine-6. Conclusion: Study's results support the evidence-based practice recommendation of adding mindfulness meditation as a complementary treatment to the nurse's care plans for patients with end-stage renal disease. Trial registration: Clinical trial.gov; ID: NCT06064708; Date: 09/26/2023.

Indexed as

C-reactive proteinend-stage renal diseaseinterleukin-6Mindfulnesstumor necrosis factor- α

Identifiers

PMID39713266
PMCPMC11660067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.